Neuroscience Research, Pfizer Global Research and Development, Princeton, New Jersey 08543, USA.
J Biol Chem. 2010 Feb 26;285(9):6425-33. doi: 10.1074/jbc.M109.071548. Epub 2009 Dec 15.
The N-terminal domain of NogoA, called amino-Nogo, inhibits axonal outgrowth and cell spreading via a largely unknown mechanism. In the present study, we show that amino-Nogo decreases Rac1 activity and inhibits fibroblast spreading. 12-O-Tetradecanoylphorbol-13-acetate-type tumor promoters, such as phorbol 12-myristate 13-acetate (PMA) and teleocidin, increase Rac1 activity and overcome the amino-Nogo-induced inhibition of cell spreading. The stimulating effect of tumor promoters on cell spreading requires activation of protein kinase D and the subsequent activation of Akt1. Furthermore, we identified Akt1 as a new signaling component of the amino-Nogo pathway. Akt1 phosphorylation is decreased by amino-Nogo. Activation of Akt1 with a cell-permeable peptide, TAT-TCL1, blocks the amino-Nogo inhibition. Finally, we provide evidence that these signaling pathways operate in neurons in addition to fibroblasts. Our results suggest that activation of protein kinase D and Akt1 are approaches to promote axonal regeneration after injury.
NogoA 的 N 端结构域,称为氨基-Nogo,通过一种很大程度上未知的机制抑制轴突生长和细胞铺展。在本研究中,我们表明氨基-Nogo 降低 Rac1 活性并抑制成纤维细胞铺展。12-O-十四烷酰佛波醇-13-乙酸酯型肿瘤促进剂,如佛波醇 12-肉豆蔻酸 13-乙酸酯 (PMA) 和 teleocidin,增加 Rac1 活性并克服氨基-Nogo 诱导的细胞铺展抑制。肿瘤促进剂对细胞铺展的刺激作用需要蛋白激酶 D 的激活以及随后 Akt1 的激活。此外,我们鉴定了 Akt1 作为氨基-Nogo 通路的一个新的信号成分。氨基-Nogo 降低 Akt1 的磷酸化。用细胞通透性肽 TAT-TCL1 激活 Akt1 可阻断氨基-Nogo 的抑制作用。最后,我们提供了证据表明这些信号通路除了成纤维细胞之外,还存在于神经元中。我们的结果表明,蛋白激酶 D 和 Akt1 的激活是促进损伤后轴突再生的一种方法。